1 month ago
14
Soumya Eswaran
Mon, April 20, 2026 astatine 8:15 AM CDT 3 min read
Michigan-based concern advisor Cedar Grove Capital Management precocious released its archetypal 4th 2026 capitalist letter. A transcript of the missive tin beryllium downloaded here. Cedar Grove Capital Management’s Multi-Strategy Composite posted a -23.0% nett instrumentality since inception, compared to -5.6% for the Russell 2000, -5.9% for the Russell Microcap, and -5.5% for the S&P 500. Timing is cardinal for aboriginal money success, yet predicting outer shocks during volatile macroeconomic periods is impossible. Rather than speculate connected macro risks, it’s advisable to put successful beardown companies astatine tenable prices with bully maturation prospects. The caller downturn, called a "SaaS apocalypse," was an accidental to bargain prime stocks that were undervalued contempt amended fundamentals and imaginable AI-driven gains. In February and aboriginal March, astir each portfolio holdings reported beardown earnings. However, the outbreak of warfare successful Iran rapidly overshadowed these gains, causing a accelerated marketplace selloff. While macro factors wounded show successful Q1, the steadfast is assured that its companies volition bash good successful Q2 and beyond. In addition, delight cheque the Strategy’s apical 5 holdings to cognize its champion picks successful 2026.
In its first-quarter 2026 capitalist letter, Cedar Grove Capital Management highlighted SANUWAVE Health, Inc. (NASDAQ:SNWV). SANUWAVE Health, Inc. (NASDAQ:SNWV) is simply a aesculapian instrumentality institution focuses connected noninvasive ultrasound oregon shockwaves technologies. On April 17, 2026, SANUWAVE Health, Inc. (NASDAQ:SNWV) closed astatine $20.61 per share. One-month instrumentality of SANUWAVE Health, Inc. (NASDAQ:SNWV) was 0.59%, and its shares mislaid 26.39% implicit the past 52 weeks. SANUWAVE Health, Inc. (NASDAQ:SNWV) has a marketplace capitalization of $177.13 million.
Cedar Grove Capital Management stated the pursuing regarding SANUWAVE Health, Inc. (NASDAQ:SNWV) successful its Q1 2026 capitalist letter:
"SANUWAVE Health, Inc. (NASDAQ:SNWV) is simply a aesculapian instrumentality institution successful the coiled attraction space. They assistance patients who person unfastened wounds — specified arsenic ulcers — to velocity up the process by utilizing a non-contact ultrasound instrumentality called ‘UltraMist.’ The process is mostly covered by security but has historically operated successful an manufacture wherever plentifulness of Medicare fraud occurs (skin grafts). In Q3’25, CMS dropped the hammer connected the tegument graft fraud by limiting however overmuch could beryllium covered nether the aged mode of doing things. This enactment unit connected the stock, fixed the uncertainty connected reimbursement rates oregon changes to CPT sum codes could impact the business. SNWV got the clarity needed and is present capable to instrumentality vantage of the changing scenery successful its favour going forward. This is connected the heels of a highly palmy indebtedness refinancing successful September of past year, on with a better-than-feared Q4’25, successful which different competitors saw deteriorating results. SNWV is small, but has a proven product, a agelong runway successful the coiled attraction abstraction present that CMS guidance has been officially updated, and the CEO looks unfastened to perchance a purchaser coming successful astatine immoderate constituent arsenic an further telephone option."
English (CA) · 
English (US) · 
Spanish (MX) ·